z-logo
open-access-imgOpen Access
Subcutaneous Enoxaparin Safely Facilitates Bedside Sustained Low-Efficiency Hemodialysis in Hypercoagulopathic Coronavirus Disease 2019 Patients—A Proof-of-Principle Trial
Author(s) -
Elke Neumann-Haefelin,
Eugen Widmeier,
Joachim Bansbach,
Kai Kaufmann,
Sebastian Heinrich,
Gerd Walz,
Hartmut Bürkle,
Johannes Kalbhenn
Publication year - 2020
Publication title -
critical care explorations
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2639-8028
DOI - 10.1097/cce.0000000000000155
Subject(s) - medicine , hemodialysis , low molecular weight heparin , heparin , renal replacement therapy , dialysis , intensive care medicine , surgery

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here